Skip to main content
. 2021 Oct 11;8:738550. doi: 10.3389/fnut.2021.738550

Table 1.

Baseline characteristics of the study population.

Characteristics Overall
n = 1,494
Demographic data
Age, years 70.76 (5.16)
Gender, male 951(63.65%)
BMI, kg/m2 22.58 (3.55)
Smoking, yes 696 (46.59%)
Alcohol, yes 289 (19.34%)
Comorbidities
    Absent 1,081 (72.36%)
    Hypertension 337 (22.56%)
    Others 76 (5.09%)
Disease data
Tumor location
    Lung 458 (30.66%)
    Digestive 759 (50.80%)
    Other 277 (18.54%)
Tumor stage:
    I 147 (9.84%)
    II 336 (22.49%)
    III 373 (24.97%)
    IV 638 (42.70%)
Chemotherapy, yes 939 (62.85%)
Radiotherapy, yes 1,494(100.00%)
Immunotherapy, yes 109 (7.30%)
Surgery, yes 357 (23.90%)
ECOG 1.09 (0.80)
Laboratory data
Albumin, g/dl 3.80 (0.53)
Cholesterol, mg/dl 182.95 (60.94)
Lymphocyte, *109/L 1.67 (1.37)
Nutritional data
CONUT, as continuous 2.30 (2.21)
Category
    Absent 672 (44.98%)
    Mild 602 (40.29%)
    Moderate 193 (12.92%)
    Severe 27 (1.81%)
PNI, as continuous 46.05 (9.90)
Category
Absent 1,320 (88.35%)
Moderate 77 (5.15%)
Severe 97 (6.49%)
NRI, as continuous 96.96 (10.32)
Category
    Absent 617 (41.30%)
    Mild 174 (11.65%)
    Moderate 607 (40.63%)
    Severe 96 (6.43%)
PG-SGA, as continuous 6.26 (4.48)
Category
    Absent 52 (3.48%)
    Mild 503 (33.67%)
    Moderate 549 (36.75%)
    Severe 390 (26.10%)
HGS, kg 22.38 (8.93)
EORTCQLQ-C30 39.21 (4.79)
PN, yes 188 (12.58%)
EN, yes 146 (9.77%)

Values are mean (SD) or n (%). BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; CONUT, Controlling Nutritional Status score; PNI, prognostic nutritional index; NRI, nutritional risk index; PG-SGA, a patient-generated subjective global assessment; HGS, handgrip strength; EORTCQLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire; PN, parenteral nutrition; EN, enteral nutrition.